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Abstract
Background: A large number of studies have demonstrated a positive effect of increased physical activity (PA) on
various health outcomes. In all large geriatric studies, however, PA has only been assessed by interview-based
instruments which are all subject to substantial bias. This may represent one reason why associations of PA with
geriatric syndromes such as falls show controversial results. The general aim of the Active-Ulm study was to
determine the association of accelerometer-based physical activity with different health-related parameters, and to
study the influence of this standardized objective measure of physical activity on health- and disability-related
parameters in a longitudinal setting.
Methods: We have set up an observational cohort study in 1500 community dwelling older persons (65 to 90
years) stratified by age and sex. Addresses have been obtained from the local residents registration offices. The
study is carried out jointly with the IMCA - Respiratory Health Survey in the Elderly implemented in the context of
the European project IMCA II. The study has a cross-sectional part (1) which focuses on PA and disability and two
longitudinal parts (2) and (3). The primary information for part (2) is a prospective 1 year falls calendar including
assessment of medication change. Part (3) will be performed about 36 months following baseline. Primary variables
of interest include disability, PA, falls and cognitive function. Baseline recruitment has started in March 2009 and
will be finished in April 2010.
All participants are visited three times within one week, either at home or in the study center. Assessments
included interviews on quality of life, diagnosed diseases, common risk factors as well as novel cognitive tests and
established tests of physical functioning. PA is measured using an accelerometer-based sensor device, carried con-
tinuously over a one week period and accompanied by a prospective activity diary.
Discussion: The assessment of PA using a high standard accelerometer-based device is feasible in a large population-
based study. The results obtained from cross-sectional and longitudinal analyses will shed light on important
associations between PA and various outcomes and may provide information for specific interventions in older people.
Background
The demographic change, especially in the industrialized
countries, will pose an extreme burden on societies: less
caregivers will have to take care of older persons and
the state budgets for care will increase [1]. Changing
family structures, increased work loads for dual career
families and smaller social networks have strongly modi-
fied living conditions of older people in these countries
[2]. Current robust data are needed, in particular to
identify (modifiable) risk factors for the onset of func-
tional decline or disability, to provide new answers to
overcome these causes of incident disability but also to
identify resources of healthy ageing. In order to address
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lation-based cohort studies are essential.
In the last years several cohort studies with older per-
sons have been conducted. Most cohorts have been
recruited in Anglo-American countries such as the
Women Health and Ageing Study, the Cardiovascular
Health Study, the Health ABC-Study or the Canadian
Study on Health and Aging [3-6]. However, there are
also some studies in Europe such as the Longitudinal
Ageing Study Amsterdam [7] or the InChianti Study in
Italy [8]. Overall, many modifiable and non-modifiable
risk factors for disability have been identified in these
projects.
Among intriguing insights into ageing and its conse-
quences, increased physical activity (PA), as a modifiable
risk factor, was found to have significant health benefits
with regard to multiple endpoints. PA had an effect on
cardiovascular health, body composition, metabolism,
bone health, psychological well-being, functional capa-
city and disability [9-16]. However, the assessment of
PA in large scale geriatric studies has often been criti-
cized as not appropriate. Most conclusions relied on
self-reported instruments with different recall periods
[17,18].
Polypharmacy is another potentially modifiable risk
factor for diverse health outcomes. The presence of
many different drugs (especially centrally acting drugs)
but also polypharmacy per se was shown to substan-
tially increase fall risk in older people [19-22] and to
significantly increase mortality [23]. Despite these
results, concomitant treatment with multiple drugs is
based mostly on standard guidelines that have been
developed on a single disease basis for mostly younger
individuals [24]. Because of these evidence-based guide-
lines, research projects that include prioritization and
medication restriction have been difficult to conduct.
However, recent efforts have shown that the use of cer-
tain algorithms could lead to a reduction of polyphar-
macy and an enhanced quality of life [25-27]. In
addition, analyses on the association and the effects of
multi-medication on certain outcomes were usually
complicated by the fact that medication-regimens often
change over time. At least in Germany, there is a lack
of current information about the incidence of multiple
medication (including “Over The Counter” drugs and
nutritional supplements).
F a l l sa r eo n eo ft h em o s ti m p o r t a n tg e r i a t r i cs y n -
dromes and are closely associated with physical function
and PA, which are two of the main objectives of the
ActiFE Ulm study. Determinants of falls have been fre-
quently analyzed [28-30]. However, in most studies the
f a c tt h a tf a l lr i s km a yb em o d i f i e db yt h et i m eo fe x p o -
sure has not been adequately examined. In this regard,
PA could be an important explanatory variable which
may alter established relationships.
To improve our knowledge on associations of the
above mentioned and other established risk factors
with PA and disability in a cross-sectional and longitu-
dinal sense, we designed the “Activity and Function in
the Elderly in Ulm” study (ActiFE Ulm). It is a large
population-based single city study, designed as the
Geriatric extension of the IMCA - Respiratory Health
Survey in the Elderly (IMCA-RHSE) which was imple-
mented in the context of the EU project “Indicators
for Monitoring COPD and Asthma - IMCA II”.W e
focused on PA because of the rising importance and
modifiability of this risk factor with regard to critical
geriatric syndromes such as functional decline, falls
and disability. Therefore, PA was assessed using accel-
erometers, self-report and activity diaries. In addition,
in a first continuous follow-up, falls and change of
medication/polypharmacy were assessed using a one-
year calendar that will be filled out by all participants.
Additional research interests of the ActiFE Ulm study
group included certain aspects of cognition, inflamma-
tion, novel biomarkers, environmental context, pain,
nutrition and others. Although the focus of ActiFE
Ulm is activity, falls and polypharmacy, the fact that it
is conducted together with the IMCA - Respiratory
Health Survey in the Elderly will allow studying more
relevant associations that go beyond the original set-
tings of both projects.
Methods/Design
Project overview
The ActiFE Ulm study is an observational cohort study
that was designed as a specific Geriatric extension of the
IMCA - Respiratory Health Survey in the Elderly
(IMCA-RHSE). Individuals included in the study were
asked to complete the IMCA-RHSE Core and Optional
questionnaires and measurements to collect baseline
data for the ActiFE Ulm longitudinal study. In addition,
for the ActiFE Ulm study PA, falls, new methods for
medication data collection and some additional geriatric
assessments were included. The ethics committee of
Ulm University has verified and agreed on the study
protocol in January 2009 (Application No. 318/08).
The establishment and definition of a community
based study population of older persons will provide a
dynamic database that - in addition to the precise study
objectives - will allow investigating a wide range of ger-
iatric-related issues, including the relationship between
biomarkers, genetic as well as physical, social, emotional
and cognitive parameters. This will ultimately increase
our insight into the complex relationship of a myriad of
promoting factors for successful ageing.
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Physical Activity
One aim was to determine reference values for the dis-
tribution and extent of PA. Therefore, standardized
values for an older population will be established via
accelerometer-based PA sensors. In addition, patterns of
PA for males and females will be identified and the rela-
tionship of PA counts with sedentary behaviour and
activity questionnaires will be explored. Selected factors
associated with a sedentary life style, such as environ-
mental conditions, weather conditions, cognitive factors,
nutritional status, body composition, frailty status, falls
history among others will be analyzed (see also figure 1).
The foci of the longitudinal setting are to investigate
the impact of PA as well as the influence of change in
PA on overall health status and on other health
trajectories.
(Change of) medication
One major goal of the ActiFE study was to gather infor-
mation about poly-pharmacy in older adults. In addition,
the associations of genetic metabolizing status with dis-
ability and PA will be in the focus of this study.
The foci of the longitudinal setting will be the associa-
tion of medication and change of medication with falls
and the effect of interactions within a medication regi-
men on disability and activity. For that purpose, valid
descriptions of all drugs, as well as tracking the change
in medication over time, were needed.
Falls
The incidence of falls among community dwelling older
people will be determined in our study, because, in Ger-
many, there are no validated epidemiologic datasets on
falls so far. The effects of certain drug groups, lower
extremity physical function and other domains with
Figure 1 Planned projects and involved partners using the example of Physical Activity. Physical activity is in the main focus of the ActiFE
Ulm study. Cooperating partners will investigate associations of several distinct risk factors and exposures with physical activity (and other
variables as mentioned in the main text).
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time of exposure (time at risk) will be included as a
T h ef o c u so ft h el o n g i t u d i n a ls e t t i n gw i l li n c l u d et h e
impact of falls on physical activity and disability at fol-
low-up.
Further aims
The comprehensive assessment protocol and careful
phenotypic characterization of the established cohort as
well as the cooperation with the IMCA-RHSE study has
enabled the creation of a useful database that will facili-
tate future research activities. This may include the ana-
lysis of diverse biomarkers in both blood and urine
specimens and their association with prevalent disease,
PA levels, functional decline or disability. Using the
example of PA, planned analysis and involved partners
are demonstrated in figure 1.
Study design
The IMCA-RHSE has a population-based cross-sectional
design. This study is implemented in five EU centres
Pisa (Italy), Rome (Italy), Barcelona (Spain), Uppsala
(Sweden) and Ulm (Germany). All partners implemen-
ted the same set of respiratory questionnaires and mea-
surements. For the centre in Ulm n = 1000 individuals
aged between 65 and 90 were randomly selected from a
population database. The details of the IMCA-RHSE
will be published elsewhere.
The ActiFE Ulm study, which is a single centre longi-
tudinal study, was designed as an add-on to the IMCA-
RHSE including a continuous 12-month follow-up mea-
surement of falls and changes in medication.
We intended to detect even small effects (as low as |r|
= .10) with a still adequate power of 0.8 - maintaining
an a-error probability of less than .05%. Taken together
these factors resulted in a sample size of at least 780
participants [31]. With regard to expected attrition rates
of about 25% per three-year intervals [32] and our
intention of at least two follow-up investigations, the
sample size was increased by n = 500 to a total of n =
1500 participants.
Some specific geriatric assessments, as suggested by
ActiFE Ulm, were also implemented in some centers of
the IMCA-RHSE as optional modules (but not including
a detailed PA measurement and without the mentioned
falls and medication calendar).
Concerning ActiFE Ulm, after completed data collec-
tion from the one year prospective falls and medication
calendar, we will conduct a follow-up (figure 2), giving
us the opportunity to estimate causal relationships
between exposures and outcomes as described in our
objectives.
Study sample
The target population was located within the greater
Ulm, Neu-Ulm and Alb-Donau-Kreis areas, including
individuals living in areas with differing urbanization
grade. For these regions other types of routinely col-
lected information existed and appropriate information
for a random sample selection were available. 1500 par-
ticipants were recruited from a representative popula-
tion-based sample (age between 65 and 90).
Recruited were non-institutionalized individuals from
the target population (including individuals living in
sheltered housing). To obtain the contact addresses, the
“Einwohnermeldeämter” (registry offices) of the involved
areas were contacted. The sample was stratified for sex
and age (three age classes). The aim of over-sampling
was to obtain comparable numbers in the respective age
groups. This also ensures the presence of older age
groups in projected follow-up studies.
Figure 2 ActiFE Ulm timeline. Baseline assessments were conducted within one week per participant. The falls- and medication-calendar
constitutes the first longitudinal follow-up (one year follow-up) and belongs to phase one. The projected second phase comprises a 3 year
follow-up with a reduced set of assessments but including physical activity.
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years; informed consent; able to walk through own room
(with or without devices). Exclusion criteria were: severe
deficits in cognition, vision or hearing that precluded the
accomplishment of most assessments. People who had ser-
ious German language difficulties were not interviewed.
Recruitment process
To enhance participation of eligible inhabitants, special
effort was dedicated to the recruitment process (see Fig-
ure 3). Up to three letters were sent out to each
sampled person: The first letter was an invitation to our
study including a detailed description of our goals and
intentions. Furthermore the legal terms of data and priv-
acy protection were explained. People that were willing
to participate were asked to either contact us by phone,
e-mail or by the included postage-free return letter.
Staff members then contacted participants to make
further arrangements for the visits.
If there was no response after the first contact, a sec-
ond letter was sent out kindly reminding the eligible
persons of our study and again asking for participation.
As advised by the Ethics Committee, recipients were
also notified that they might be contacted by phone if
there was public access to their phone number. People
that liked to participate after the second letter were
asked to contact us by phone or mail and/or were con-
tacted by staff members for further agreements.
If again there was no (negative or positive) response,
phone operators were calling those whose telephone
numbers were publicly accessible and tried to obtain a
definite response about participation or non-
participation.
Furthermore, people stating their refusal on the phone
were generally asked to answer a small set of questions
summarized in a short questionnaire (see table 1). That
information will allow us to estimate the possible bias
non-respondents may create in our population.
Finally, those people that were neither attainable by
phone nor by the first two invitations received a third
letter. In this letter, which was clearly marked as the
final letter, we included the short questionnaire and
Figure 3 Recruitment process of the ActiFE Ulm study. Flowchart on the effort that was made to improve recruitment.
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Domain Type of Assessment Notes Origin
Physical activity Accelerometer (activPAL™) Continuously over 7 days From ActiFE Ulm
Activity diary Own development From ActiFE Ulm
LAPAQ From the LASA study - Amsterdam From IMCA-RHSE
Optional Q
Physical functioning Short Physical Performance Battery From IMCA-RHSE
Optional Q
Basal and Instrumental Activities of Daily
Living
From the LASA study including additional items From ActiFE Ulm
Handgrip Strength JAMAR dynamometer From IMCA-RHSE
Optional Q
Falls risk factors Prospective 1 year falls calendar Own development From ActiFE Ulm
Falls history 3 and 12 months From ActiFE Ulm
Level of fatigue, level of dizziness Numerical rating scales From ActiFE Ulm
Falls Efficacy Scale - International; Short
Form
Falls-related self efficacy From ActiFE Ulm
Medication Medication barcode scan By hand if no barcode available From IMCA-RHSE
Core Q
Prospective 1 year “change of medication
calendar”
Own development From ActiFE Ulm
Incontinence International Consultation on Incontinence
Q. - Short Form
Including additional items on overactive bladder and
fecal incontinence
From ActiFE Ulm
Affective state Psychological distress, exhaustion Numerical rating scales From ActiFE Ulm
Hospital Anxiety and Depression Scale From IMCA-RHSE
Optional Q
Medical status and
medical history
Medical history/Comorbidity Functional Comorbidity Index can be derived from
items
From IMCA-RHSE
Core Q
Respiratory risk factors including smoking From IMCA-RHSE
Core Q
Alcohol Derived from MONICA From ActiFE Ulm
Near vision Snellens’ Tumbling E’s From ActiFE Ulm
Hearing Interviewers’ impression From ActiFE Ulm
Height/weight Digitally measured From IMCA-RHSE
Core M
Lung function (pre- and post-
bronchodilatator spirometry)
Digitally measured From IMCA_RHSE
Core M
Structured Pain Interview Abbreviated version From ActiFE Ulm
Blood pressure, heart rate and oxygen
saturation
Digitally measured From IMCA-RHSE
Core M
Cognition Mini Mental State Exam From IMCA-RHSE
Optional Q
Category fluency From ActiFE Ulm
Letter sorting From ActiFE Ulm
Episodic Memory, word list learning From ActiFE Ulm
Episodic Memory, visual Memory From ActiFE Ulm
Cognitive estimation tasks From ActiFE Ulm
Subjective health Short Form - 12 (Quality of Life) From IMCA-RHSE
Optional Q
Nutrition Dietary supplements Vitamins, minerals, yeast, garlic, fibre, others From IMCA-RHSE
Optional Q
Mini Nutritional Assessment From IMCA-RHSE
Optional Q
Body Composition 3-point calliper examination From ActiFE Ulm
Social context Environmental context Selected questions from the ENABLE-AGE Project From IMCA-RHSE
Optional Q
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non-participation.
During the progress of the study we realized that the
time used for phone recruitment after the second letter
was not worth the effort: less than five percent of those
contacted could be recruited in addition. This small suc-
cess was further derogated by the fact that those who
agreed to participate were mostly interested anyway, and
had just not turned in their consent yet. Response rates
showed virtually no difference after we had decided to
directly send out a third letter instead of calling.
Data collection
Participants satisfying the inclusion criteria were con-
tacted by a field worker to make an individual appoint-
ment for an interview at home. Participants who did not
want to be visited in their home were given the alterna-
tive to meet the interviewer in a designated room
located at the Bethesda Geriatric Clinic, Ulm.
In total there were three visits incorporated in the
ActiFE Ulm study, all to be completed within seven
days. The first and last visits were conducted by a study
nurse, the visit in between by a physician.
During the first visit the interviewer obtained
informed consent from the participant, provided infor-
mation about the study procedure and conducted the
first half of the baseline interview. Furthermore the
accelerometer was started and attached to the leg of the
participant and the activity diary was handed out. Writ-
ten information about the physician’s visit was distribu-
ted. The second visit was conducted by a physician,
performing all the clinical assessments that are part of
t h eI M C A - R H S Ea n dj u s tasmall set of ActiFE Ulm
questions. In the last visit the interviewer accomplished
the second half of the baseline interview and detached
the activity monitor. Before concluding, the prospective
one year falls and medication calendar was handed out
and explained extensively. Both study nurse visits lasted
approximately 90 minutes each, the doctor’sv i s i tw a s
done after an hour. Measures included in the ActiFE
Ulm study are described in more detail below and are
summarized in table 1. They were thoughtfully selected
to achieve the best possible and conclusive set of para-
meters while also trying not to challenge participants
with too time consuming sessions. The importance of
this trade-off to maximize clinical research participation
and to accomplish valid answers has been pointed out
before in a recent article by Marcantonio et al. [33].
Home interview
The home interview included a selected set of validated
questionnaires as well as new instruments that will be
evaluated in the course of data analysis. As stated earlier
the survey consisted of assessments that were derived
from IMCA-RHSE and ActiFE Ulm. The IMCA-RHSE
study protocol will be published in detail elsewhere.
B r i e f l y ,t h ec o r eq u e s t i o n n aires included questions on
socio-demographic characteristics, diagnosis and related
respiratory symptoms of asthma and COPD, comorbid-
ity, exposures and potential risk factors related to these
two conditions, clinical management (treatment and self
management issues), accessibility and use of health ser-
vices and outcome measures. Clinical assessments that
were carried out as part of the IMCA-RHSE study were
Table 1 Complete overview on assessments used in the ActiFE Ulm study (Continued)
Lubben Social Network Scale 6-item version From IMCA-RHSE
Optional Q
emotional loneliness Numerical rating scale
Health care utilization Hospital/outpatient health care utilization From IMCA-RHSE
Core Q
Specimens Blood: EDTA, Serum, Lithium-Heparin Separate informed consent From ActiFE Ulm
Urine Mid stream morning void
Short Questionnaire 8 selected questions on COPD/Asthma From IMCA-RHSE
2 ADL Questions From ActiFE Ulm
1 question on Physical Activity From ActiFE Ulm
Demographics From IMCA-RHSE
ActiFE Ulm = Activity and Function in the Elderly in Ulm
ADL = Activities of Daily Living
COPD = Chronic Obstructive Pulmonary Disease
EDTA = Ethylenediaminetetraacetate
ENABLE-AGE = Enabling Autonomy, Participation and Well-Being in Old Age: The Home Environment as a Determinant for Healthy Ageing
IMCA-RHSE = Indicators for Monitoring COPD & Asthma - Respiratory Health Survey in the Elderly
LAPAQ = Longitudinal Ageing Study Amsterdam Physical Activity Questionnaire
LASA = Longitudinal Ageing Study Amsterdam
MONICA = Monitoring Cardiovascular disease
Q. = Questionnaire
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and weight and pre- and post bronchodilatator spirome-
try. The IMCA-RHSE Optional questionnaire and mea-
surements contained assessments that were mainly
implemented in the Ulm and Barcelona centres. Further
details are described below and listed in table 1. Those
assessments derived from IMCA-RHSE are also listed in
table 1 in order to give a comprehensive picture of the
study.
The ActiFE Ulm Assessments
Physical Activity
To be able to accurately measure physical activity we
used accelerometers that record active and sedentary
periods during everyday life for one week. Within the
seven-day measurement period, activity diaries were
kept to collect information about outdoor activities
(intended purpose, time spent outdoors, modality, etc.).
In order to obtain a comprehensive overview, a PA
questionnaire was included and administered during the
home visits.
PA sensor PA was predominantly measured using accel-
erometers with uniaxial movement sensors, called activ-
PAL™ (PAL Technologies Ltd., Glasgow, UK). These
monitors were attached to the thigh of the participants
to record activity for a continuous period of seven days.
Participants were encouraged to contact the study man-
ager if they would experience any problems and they
were informed that, in serious cases, the monitor could
be removed at any time. The validity of this monitor has
been examined numerous times [34,35].
The activPAL™ differentiates activities by the three
categories sitting, standing and walking. The definition
of sit/lie, stand and move/walk (including the cadence
of walking) will provide stable information on the preva-
lence of activity as well as on detailed aspects such as
activity patterns.
Activity diary Outdoor activity was recorded using
activity diaries for the duration the monitor was
attached. Participants werea s k e dt of i l li naq u e s t i o n -
naire on a daily basis. That included a question about
the persons’ well being and the subjectively perceived
weather situation as well as a specific query on the
times leaving and returning home, the purpose of the
activity, the distance covered, the vehicle used and if the
participant was accompanied by other persons.
The LASA PA Questionnaire The Longitudinal Aging
Study Amsterdam Physical Activity Questionnaire
(LAPAQ, Voorrips et al. [36] and Caspersen et al. [37])
examines the frequency and duration of specific types of
activity in the past two weeks. The total time spent on
PA can be calculated by multiplying the frequency and
duration of each activity and summing these values
across activities. The LAPAQ has been validated against
PA diaries and pedometer counts in a subsample of the
LASA population [38] and it has demonstrated good
repeatability and moderate validity (similar to other PA
questionnaires to date).
Physical functioning
The Short Physical Performance Battery
The Short Physical Performance Battery (SPPB) is used
to measure lower extremity function by means of tasks
that mimic daily activities. It includes a balance test, a
g a i ts p e e dt e s tt h a tm e a s u r e st h et i m er e q u i r e dt ow a l k
four meters at a normal pace and the ability and time to
rise from a chair five times. The covered areas represent
essential tasks important for independent living and are
thus an important outcome or independent variable for
all older patients [39]. The SPPB is a frequently used
instrument that was shown to be valid not only in iden-
tifying and characterizing subjects at the disabled end of
the functional spectrum but also in non-disabled, higher
functioning older persons [39].
(Instrumental) Activities of Daily Living Another facet
of physical functioning is the performance of basic tasks
in everyday life (Activities of Daily Living, ADL) and of
those that are not necessary for fundamental functioning
but ensure independence within the community (con-
cept of Instrumental Activities of Daily Living, IADL).
Emerged from LASA, the ActiFE Ulm study imple-
ments the same seven (I)ADL questions as used in
L A S A .I na d d i t i o nw ed e f i n e dt h r e ee x t r ai t e m st h a t
cover further aspects and that have proven useful in dif-
ferent settings, resulting in a 10 item IADL scale [40].
The answering format will be comparable to those used
in recent functional activity questionnaires [41] and
includes the differentiation between dependent and
independent.
Handgrip strength The measurement of handgrip
strength is an efficient and simple method to estimate
overall strength in older people. It has been shown to be
highly and independently predictive of functional limita-
tions and disability [42].
Assessment of falls and of risk factors for falls
T h ef a l lh i s t o r yd u r i n gt h ep a s tt w e l v em o n t h sw a s
asked retrospectively and information on falls was also
assessed prospectively by a falls calendar. The ActiFE
Ulm study used a falls calendar over a time-period of
one year which is filled out by the participants on a
weekly basis and sent in to the study center every three
months. In order to maximize participants’ compliance
reminders were sent out every six weeks by the study
center. If the calendars did not return within two weeks
after they were expected participants were additionally
contacted by phone. Thus, recall bias was avoided by
the prospective assessment of falls and an impression of
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history.
For the assessment of falls-related self-efficacy the
Short Form of the Falls Efficacy Scale-International was
used. It has been shown to be highly related to previous
and subsequent falling [43].
Level of fatigue and level of dizziness may constitute
meaningful risk factors for falls [44]. Fatigue was mea-
sured using a numerical rating scale from 0 to 10, dizzi-
ness using a 5 point Likert scale.
Furthermore, many established risk factors of falls
such as muscle strength, balance, cognition, specific
comorbidities, loss of vision or the number and type of
drugs [29,30] were assessed.
Medication
Barcode Scan
To assess drugs and medications of our population we
scanned the barcodes of every pharmaceutical available
in the participants’ home. In addition, we asked for
dosage, frequency and how often in the past twelve
months the drug was taken.
In scanning the medication we avoided spelling mis-
takes, gathered precise information about the pharma-
ceutical and were able to develop various medication
classes for future evaluation. Medications without avail-
able barcodes (packages lost, other reasons) were
entered by hand.
Medication calendar
Analogous to the prospective assessment of falls any
change of medication was documented in a second
sheet included in the falls calendar. Likewise it was to
be filled in on a weekly basis and sent in every three
months.
Hearing and Vision
Impaired hearing has been shown to correlate with poor
mobility and may also precede mobility decline [45]. It
was assessed using a subjective evaluation by the inter-
viewer using a 4-point Likert scale.
Vision has been found to influence falls in older peo-
ple; however it is not clear yet if it is an independent
risk factor or if it is mediated by PA [46]. In the ActiFE
Ulm study near vision is measured using the well
known Snellens eye chart (tumbling E’s) [47].
Cognition
Category fluency
A test of verbal fluency was applied to measure cogni-
tive flexibility and speed of access to semantic informa-
tion [48].
Episodic memory
Impairment of verbal and visual episodic memory is a
hallmark of early dementia, especially dementia of the
Alzheimer type. We used word list learning from the
CERAD battery [49] in its German adaptation [50]. For
assessment of visual episodic memory we composed a
new test that required learning a list of abstract symbols.
Letter sorting
Working memory and concentration were assessed with
the Letter sorting test [51].
Cognitive estimation tasks
Cognitive estimation included items with the four
dimensions “length”, “weight”, “quantity” and “time” and
required only numerical answers [52,53].
Psychological distress, exhaustion
Exhaustion and psychological distress were determined
on a numerical 10-point rating scale.
General exhaustion over the past four weeks was
assessed as well as the specific exhaustion respective to
a former completed difficult cognitive task.
Pain
The “structured pain interview” [54] has been developed
for cognitively intact and cognitively impaired geriatric
patients suffering from pain. The assessment consists of
different questions about location, duration, intensity
and frequency of pain. We have implemented a reduced
version without the screening questions on cognition
and functional capacity; both aspects have been covered
by other instruments in our questionnaire.
Urinary and fecal Incontinence
The “International Consultation on Incontinence Ques-
tionnaire - Short Form” (ICIQ-SF) is a brief question-
naire that can be interview-based or self-administered. It
was originally developed and validated by Avery et al
[55]. It provides a rapid evaluation of the impact of
urinary incontinence on quality of life and classifies
urinary losses experienced by patients of both sexes
[56]. We added a question on urinary urge (overactive
bladder) including urge incontinence and two questions
on fecal incontinence.
Nutrition
Mini Nutritional Assessment
The Mini Nutritional Assessment (MNA) is a simple
and well-validated screening tool for malnutrition in
older persons. The 18-item questionnaire includes
anthropometric measurements combined with a ques-
tionnaire regarding dietary intake, a global assessment of
life style as well as the subjective perception of health
and nutrition [57].
Dietary supplements
Data on the regular use of dietary supplements has been
collected. Regular use was defined as ‘application for at
least for four weeks during the past year’. If the answer
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mineral from a list of commonly used vitamins and
minerals or they could add other supplements. Partici-
pants were asked whether they used preparations with a
single component or the combination of different vita-
mins and/or minerals. Besides vitamins and minerals,
information on the supplement use of yeast, garlic and
fiber has been collected [58,59].
Body Composition/Skin thickness
The abdominal fat percentage was determined by waist
circumference, which was measured in a standing posi-
tion at the level of the umbilicus. Total body fat content
was measured using a standardized assessment of three
subcutaneous skin-folds according to Jackson and Pol-
lock [60,61] with a Harpenden-Caliper (three different
points on one side of the body; for men: chest, abdomen
and legs; for women: triceps, abdomen and leg).
Alcohol
In order to assess levels of alcohol consumption we
implemented the instrument used in the MONICA
Augsburg study which is integrated in the WHO’s
worldwide MONICA project. Each subject is asked how
much beer, wine, and spirits he or she drank on the pre-
vious workday and over the last weekend. Total alcohol
intake is calculated by multiplying weekday consump-
tion by five and adding this figure to weekend consump-
tion. After conversion (1 litre beer = 40 g, 1 litre wine =
100 g, 0.02 litre spirits = 6.2 g alcohol) an average
amount of alcohol intake in grams per day can be
derived.
This recall method was validated in a subsample of
899 male participants of the first MONICA Augsburg
survey in 1984/85, who additionally completed a seven-
day dietary record [62].
Social context
Growing empirical evidence demonstrates the impor-
tance of social networks and support to both physical
health and well-being among older people [63]. To
depict the social networks of our participants, the Lub-
ben Social Network Scale (LSNS) was used. The LSNS
is a brief instrument designed to evaluate the size of the
social network, perceived support network and perceived
confidant network, differentiating between friends and
neighbours. It was originally developed in 1988 and was
revised in 2002 (LSNS-R) along with an abbreviated ver-
sion (LSNS-6) which was used in our study [64,65]. A
subjective estimation of emotional loneliness was added
using a 10 point visual analogue scale.
Environmental context
The present and past living situation in regard to the
level of the floor participants live/lived and the number
of steps which have/had to be climbed were asked for in
detail. In addition, personal preferences about the indivi-
dual living situation were assessed using questions from
the ENABLE-AGE Project [66].
Laboratory Measures
If participants had separately agreed, blood was collected
during the second visit (physician) in the following
order: Serum, EDTA and Lithium-Heparin. Participants
who were successfully instructed on visit one, also pro-
vided mid-stream urine (morning void).
Baseline laboratory tests included a complete blood
cell count, levels of albumin, creatinine, cholesterol,
high density lipoprotein, low density lipoprotein, glu-
cose, gamma-glutamyl transferase, uric acid and urea.
Blood and urine specimens were stored for analysis of
biomarkers, vitamins, hormones, micronutrients and
genetic analyses.
Discussion
The approach of our project differs considerably from
other national and international studies by its predomi-
nant focus on activity, medication and falls. With an
over-sampling of age groups IMCA-RHSE and ActiFE
Ulm is a study with a high number of individuals in the
highest age groups. This was needed to adequately pic-
ture associations between activity, change of medication,
biomarkers of ageing, respiratory disease, falls and their
impact on function and autonomy in these steadily
growing age-groups.
The cooperation with the IMCA-RHSE will bring
mutual benefits combining detailed information on
respiratory disease, including high standard pre- and
post-bronchodilatator spirometry, and comprehensive
geriatric assessments. In the German IMCA-RHSE and
ActiFE datasets this will allow detailed analyses on the
associations of respiratory diseases with geriatric syn-
dromes and its impact on disability in follow-up studies.
Furthermore, certain analyses can be carried out on a
larger international dataset, because aspects from the
presented ActiFE Ulm study have been included as
optional modules in the European IMCA-RHSE. The
enriching collaboration with IMCA and the various Ulm
University partners led to important choices regarding
the selection of assessment instruments used in this
study. Our goal was to minimize the impact of the over-
all data collection on the participants, while attempting
to gather all the relevant data that would allow us to
adequately examine the objectives of our study. Hence,
we had to be concise while not missing important geria-
tric domains. We believe that this parsimonious
approach can be feasible for several parameters like for
the assessment of activities of daily living (e.g. practiced
in the LASA study) [67] but also for social networking,
hearing, vision and other parameters.
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diverse facets of this important domain. So far, in all
large Geriatric studies, PA was assessed via self report
which is prone to systematic error and typically asso-
ciated with poor validity [17,18,68,69]. In a study on
physical frailty in hospitalized older people, engagement
in PA was even estimated using proxy items that reflect
rather functional and physical capacities than real PA
[70,71]. Moreover, PA was rarely available as a continu-
ous variable, considerably reducing statistical power.
Recent data suggest that adequate assessment of PA in
older people has to involve objective measurements [18].
However, the direct measurement of PA is challenging,
often costly and, for large studies, not all standardized
PA assessments are feasible. For example, the standard
double labeled water technique and the measurement of
oxygen consumption by minute to minute heart rate or
ventilation masks can only be used in laboratory settings
and are impractical for the assessment during everyday
live in the community [72,73]. It is now widely accepted
that the most attractive and objective method to date
are accelerometer- or pedometer-based sensors [18].
To be able to study patterns of PA in 1500 partici-
pants in conjunction with overall activity counts we had
to find a monitor that provided enough detail with a
reasonable amount of storable data. We decided to use
the activPAL™ monitor (PAL technologies Ltd., Glasgow,
Scotland) for several reasons: First of all this monitor is
small and not compromising quality of life for the
recording time span. Second, since it is attached to the
leg using adhesive film unlike other monitors that are
integrated in a belt it is certain to remain on the leg for
the intended period of time. Third, it is a uniaxial sensor
with a reasonable amount of data recorded over a seven
days period (without the need to change batteries).
Fourth, being attached to the thigh, it allows for the dif-
ferentiation of sedentary (sitting, lying) and active
(standing, walking) periods.
When developing the activity diary we decided to
focus on outdoor activities because this reflected the
most important contribution to overall activity and it is
better remembered as compared to indoor activity
(which involves high assessment efforts and misclassifi-
cation). In addition, we particularly developed the activ-
ity diary to complement the objective measurement of
PA and to add specific details on patterns of activity
that can contribute to an exhaustive analysis of PA.
Since the relationship of PA with health outcomes may
differ by the type of activities [74,75], we also needed to
discriminate between different intensities of activity. A
simple method to take intensity into account is to dis-
tinguish sports activities from non-sports activities. For
that purpose the LASA Physical Activity Questionnaire
(LAPAQ) was incorporated into the study protocol.
PA is often understood as some kind of (even low
intensity) sports. However, studies showing that even a
one hour walk per week already results in a reduced
risk for cardiovascular events should not be ignored
[76]. Therefore, habitual PA-levels could be of interest
to both researchers and health care authorities allowing
disentangling the patterns of PA, different for age, sex
and/or social status. This could be helpful in terms of
future preventive measures and programs. In order to
monitor future interventions, standardized normative
values across different age-groups should be of major
interest. This involves a comparison of the accuracy of
current activity questionnaires with a standardized activ-
ity sensor. Moreover, prevailing hypotheses of the above
mentioned associations of PA with other health out-
comes or with healthy ageing could be verified using
these new techniques.
At present, some of the results on PA are conflicting.
For example the association of falls and disability in the
context of PA is largely unknown [77] although the inci-
dence of falls among community-dwelling older people
aged 65 years or older is approximately 30% per year
[28] and the individual (fractures/immobility) [29] and
economical costs are substantial: therapy-costs of the
proximal hip fractures in Germany run up to € 500 mil-
lion per year [78]. Therefore, there is a need for strate-
gies to prevent falls and fall-related injuries in older
people on the individual and the community level. This
is, however, problematic since both high and low levels
of PA have been linked to an increase in falls risk (in a
linear or U-shaped relation) and the association could
be highly influenced by physical function. To our knowl-
edge only few studies have been designed in a (metho-
dologically) adequate way to make any assumptions
about this relation [77,79,80].
Associations between drug groups and falls have been
previously reported [20-22]. Most data derived from
cross-sectional or retrospective studies. In the ActiFE
Ulm study change of medication and incidence of falls
were assessed both simultaneously and prospectively. To
t h eb e s to fo u rk n o w l e d g et h i sh a sn o tb e e nd o n e
before. In addition, most research focused on antece-
dents of falls whilst there is less information on the
long-term consequences of falls other than injury or
mortality.
With regard to polymedication it is well known by
both clinicians and researchers alike that potentially
appropriate medications for one diagnosis could worsen
other diagnoses. Because of the difficulty to maximize
benefits for all conditions in comorbid older persons it
is essential to carefully weigh risks and benefits. E.g. fall
risk, hypertension and adverse medication effects repre-
sent frequent trade-off situations in older adults [81].
Especially associations of PA and polypharmacy or
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intense research activities [82]. Polypharmacy per se has
been associated with falls and even mortality in older
persons [22,23,83].
When looking at medication effects, potential interac-
tions (CYP-enzymes, the individuals’ metabolic status
such as rapid versus slow metabolizers, etc.) have to be
considered. These complex associations demand large
cohort sizes and precise outcome assessments. To our
knowledge, a comparable prospective assessment of
medication change over one year has not been per-
formed before in an older population. With a detailed
assessment of medication use we will be able to evaluate
the influence of inappropriate medication and the influ-
ence of medication change on all mentioned outcome
measures.
The ActiFE Ulm study includes both performance-
based and self-rated assessments to measure physical
function as suggested in a recent consensus-paper [84].
Questionnaires regarding physical performance add an
important aspect to the overall description of physical
functioning: while outcomes of performance tests clearly
depend on one concrete situation, questionnaires are
able to depict physical functioning as a subjective per-
ception averaged over a longer period of time.
The study started as a cross-sectional project in coop-
eration with the IMCA-RHSE study extended by a con-
tinuous one year follow-up which was restricted to falls
and change of medication. However, an established
cohort with such a high number of older and very old
individuals offers unique opportunities for longitudinal
investigations. Therefore, a three years follow-up with
focus on PA, disability, mortality and institutionalization
is projected as outlined in figure 2. Further follow-up
studies and auxiliary studies are desirable, already in
preparation or will be planned in the near future.
We hope that the ActiFE Ulm study will shed light on
the accuracy of reported PA, will allow for the estima-
tion of standard PA counts in older persons, their distri-
bution over time and on the impact of PA on falls or its
association with certain medication changes. This again
could influence public health PA programs and help to
find the right treatment for these often poly-morbid
older persons. The detailed fall-calendars will help ana-
lyzing these rather intimate personal stories. The ActiFE
Ulm Team is looking forward to the end of the first
recruitment period and invites interested Geriatric or
Epidemiologic researchers to participate in our study.
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